Publications by authors named "Michael Repajic"

Purpose: To evaluate conflicts of interest (COIs) among interventional radiologists and related specialties who mention specific devices or companies on the social media (SoMe) platform X, formerly Twitter.

Materials And Methods: In total, 13,809 posts between October 7, 2021, and December 31, 2021, on X were evaluated. Posts by U.

View Article and Find Full Text PDF

Purpose: To evaluate the trends and patterns of cervical degenerative disc disease in the cervical spine in different age groups of symptomatic patients.

Methods: Overall, 1300 symptomatic patients who had undergone cervical spine MRI from February 2019 to November 2021 were included. Pfirrmann grading was used to evaluate the IVD degeneration.

View Article and Find Full Text PDF

Twenty-seven months into the current pandemic and 18 months after vaccinations were made available, there are still relatively limited data on the incidence of recurrent Bell's Palsy after the administration of mRNA-based vaccines. The authors continue to believe that it is through rigorous reporting that the true incidence can be tabulated eventually.

View Article and Find Full Text PDF

Miller Fisher Syndrome (MFS), a variant of Guillain Barre Syndrome (GBS), and amyotrophic lateral sclerosis (ALS) are two rare neuromuscular diseases that are usually unrelated. While ganglioside antibodies have a common relation with MFS and GBS, they have also been found in association, albeit less commonly, with ALS. A patient experiencing MFS and then ALS in tandem has never been documented.

View Article and Find Full Text PDF

Purpose: This study aimed to analyse the trends and patterns of IVD degeneration in different age groups at each level of the thoracic spine.

Methods: This cross-sectional MRI study included 1000 symptomatic patients who had undergone upright thoracic spine MRI. A total of 13,000 thoracic IVDs from C7/T1 to T12/L1 were classified into five grades using Pfirrmann classification.

View Article and Find Full Text PDF

Objective: To report a patient with history of recurrent Bell's Palsy who developed Bell's Palsy 36 ​h after the administration of the second dose of the Pfizer-BioNTech COVID-19 vaccine.

Case: The patient is a 57-year-old female with past medical history of 3 episodes of Bell's Palsy. She responded to prednisone treatment and returned to her baseline after each occurrence.

View Article and Find Full Text PDF